Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell Therapy
1.2.3 Gene Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Solutions Market Perspective (2018-2029)
2.2 Cell and Gene Therapy Solutions Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell and Gene Therapy Solutions Historic Market Size by Region (2018-2024)
2.2.3 Cell and Gene Therapy Solutions Forecasted Market Size by Region (2024-2029)
2.3 Cell and Gene Therapy Solutions Market Dynamics
2.3.1 Cell and Gene Therapy Solutions Industry Trends
2.3.2 Cell and Gene Therapy Solutions Market Drivers
2.3.3 Cell and Gene Therapy Solutions Market Challenges
2.3.4 Cell and Gene Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Solutions Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Solutions Players by Revenue (2018-2024)
3.1.2 Global Cell and Gene Therapy Solutions Revenue Market Share by Players (2018-2024)
3.2 Global Cell and Gene Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Solutions Revenue
3.4 Global Cell and Gene Therapy Solutions Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Solutions Revenue in 2022
3.5 Cell and Gene Therapy Solutions Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Solutions Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Solutions Breakdown Data by Type
4.1 Global Cell and Gene Therapy Solutions Historic Market Size by Type (2018-2024)
4.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2024-2029)
5 Cell and Gene Therapy Solutions Breakdown Data by Application
5.1 Global Cell and Gene Therapy Solutions Historic Market Size by Application (2018-2024)
5.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell and Gene Therapy Solutions Market Size (2018-2029)
6.2 North America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
6.4 North America Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Solutions Market Size (2018-2029)
7.2 Europe Cell and Gene Therapy Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
7.4 Europe Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Solutions Market Size (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2018-2024)
8.4 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Solutions Market Size (2018-2029)
9.2 Latin America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
9.4 Latin America Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Solutions Market Size (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2018-2024)
10.4 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Detail
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Cell and Gene Therapy Solutions Introduction
11.1.4 Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.1.5 Bluebird Bio Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Introduction
11.2.4 Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Solid Biosciences
11.3.1 Solid Biosciences Company Detail
11.3.2 Solid Biosciences Business Overview
11.3.3 Solid Biosciences Cell and Gene Therapy Solutions Introduction
11.3.4 Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.3.5 Solid Biosciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cell and Gene Therapy Solutions Introduction
11.4.4 Novartis Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.4.5 Novartis Recent Development
11.5 Biomarin Pharmaceutical
11.5.1 Biomarin Pharmaceutical Company Detail
11.5.2 Biomarin Pharmaceutical Business Overview
11.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Introduction
11.5.4 Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.5.5 Biomarin Pharmaceutical Recent Development
11.6 Uniqure
11.6.1 Uniqure Company Detail
11.6.2 Uniqure Business Overview
11.6.3 Uniqure Cell and Gene Therapy Solutions Introduction
11.6.4 Uniqure Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.6.5 Uniqure Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Introduction
11.7.4 Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Alaunos Therapeutics
11.8.1 Alaunos Therapeutics Company Detail
11.8.2 Alaunos Therapeutics Business Overview
11.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Introduction
11.8.4 Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.8.5 Alaunos Therapeutics Recent Development
11.9 Homology Medicines
11.9.1 Homology Medicines Company Detail
11.9.2 Homology Medicines Business Overview
11.9.3 Homology Medicines Cell and Gene Therapy Solutions Introduction
11.9.4 Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.9.5 Homology Medicines Recent Development
11.10 Biogen
11.10.1 Biogen Company Detail
11.10.2 Biogen Business Overview
11.10.3 Biogen Cell and Gene Therapy Solutions Introduction
11.10.4 Biogen Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.10.5 Biogen Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Detail
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Cell and Gene Therapy Solutions Introduction
11.11.4 Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.11.5 Legend Biotech Recent Development
11.12 CARsgen
11.12.1 CARsgen Company Detail
11.12.2 CARsgen Business Overview
11.12.3 CARsgen Cell and Gene Therapy Solutions Introduction
11.12.4 CARsgen Revenue in Cell and Gene Therapy Solutions Business (2018-2024)
11.12.5 CARsgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stem Cell Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Other
Table 5. Global Cell and Gene Therapy Solutions Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell and Gene Therapy Solutions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cell and Gene Therapy Solutions Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Cell and Gene Therapy Solutions Market Share by Region (2018-2024)
Table 9. Global Cell and Gene Therapy Solutions Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cell and Gene Therapy Solutions Market Share by Region (2024-2029)
Table 11. Cell and Gene Therapy Solutions Market Trends
Table 12. Cell and Gene Therapy Solutions Market Drivers
Table 13. Cell and Gene Therapy Solutions Market Challenges
Table 14. Cell and Gene Therapy Solutions Market Restraints
Table 15. Global Cell and Gene Therapy Solutions Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Cell and Gene Therapy Solutions Market Share by Players (2018-2024)
Table 17. Global Top Cell and Gene Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2022)
Table 18. Ranking of Global Top Cell and Gene Therapy Solutions Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Solutions Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell and Gene Therapy Solutions Product Solution and Service
Table 22. Date of Enter into Cell and Gene Therapy Solutions Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell and Gene Therapy Solutions Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2018-2024)
Table 26. Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cell and Gene Therapy Solutions Revenue Market Share by Type (2024-2029)
Table 28. Global Cell and Gene Therapy Solutions Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Cell and Gene Therapy Solutions Revenue Market Share by Application (2018-2024)
Table 30. Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cell and Gene Therapy Solutions Revenue Market Share by Application (2024-2029)
Table 32. North America Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Cell and Gene Therapy Solutions Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Cell and Gene Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 47. Bluebird Bio Company Detail
Table 48. Bluebird Bio Business Overview
Table 49. Bluebird Bio Cell and Gene Therapy Solutions Product
Table 50. Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 51. Bluebird Bio Recent Development
Table 52. Sarepta Therapeutics Company Detail
Table 53. Sarepta Therapeutics Business Overview
Table 54. Sarepta Therapeutics Cell and Gene Therapy Solutions Product
Table 55. Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 56. Sarepta Therapeutics Recent Development
Table 57. Solid Biosciences Company Detail
Table 58. Solid Biosciences Business Overview
Table 59. Solid Biosciences Cell and Gene Therapy Solutions Product
Table 60. Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 61. Solid Biosciences Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Cell and Gene Therapy Solutions Product
Table 65. Novartis Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Biomarin Pharmaceutical Company Detail
Table 68. Biomarin Pharmaceutical Business Overview
Table 69. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product
Table 70. Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 71. Biomarin Pharmaceutical Recent Development
Table 72. Uniqure Company Detail
Table 73. Uniqure Business Overview
Table 74. Uniqure Cell and Gene Therapy Solutions Product
Table 75. Uniqure Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 76. Uniqure Recent Development
Table 77. Spark Therapeutics Company Detail
Table 78. Spark Therapeutics Business Overview
Table 79. Spark Therapeutics Cell and Gene Therapy Solutions Product
Table 80. Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 81. Spark Therapeutics Recent Development
Table 82. Alaunos Therapeutics Company Detail
Table 83. Alaunos Therapeutics Business Overview
Table 84. Alaunos Therapeutics Cell and Gene Therapy Solutions Product
Table 85. Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 86. Alaunos Therapeutics Recent Development
Table 87. Homology Medicines Company Detail
Table 88. Homology Medicines Business Overview
Table 89. Homology Medicines Cell and Gene Therapy Solutions Product
Table 90. Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 91. Homology Medicines Recent Development
Table 92. Biogen Company Detail
Table 93. Biogen Business Overview
Table 94. Biogen Cell and Gene Therapy Solutions Product
Table 95. Biogen Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. Legend Biotech Company Detail
Table 98. Legend Biotech Business Overview
Table 99. Legend Biotech Cell and Gene Therapy Solutions Product
Table 100. Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 101. Legend Biotech Recent Development
Table 102. CARsgen Company Detail
Table 103. CARsgen Business Overview
Table 104. CARsgen Cell and Gene Therapy Solutions Product
Table 105. CARsgen Revenue in Cell and Gene Therapy Solutions Business (2018-2024) & (US$ Million)
Table 106. CARsgen Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Solutions Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Cell and Gene Therapy Solutions Market Share by Type: 2022 VS 2029
Figure 3. Stem Cell Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Other Features
Figure 6. Global Cell and Gene Therapy Solutions Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Cell and Gene Therapy Solutions Market Share by Application: 2022 VS 2029
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Cell and Gene Therapy Solutions Report Years Considered
Figure 12. Global Cell and Gene Therapy Solutions Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cell and Gene Therapy Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cell and Gene Therapy Solutions Market Share by Region: 2022 VS 2029
Figure 15. Global Cell and Gene Therapy Solutions Market Share by Players in 2022
Figure 16. Global Top Cell and Gene Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Solutions as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Solutions Revenue in 2022
Figure 18. North America Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 20. United States Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 24. Germany Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Solutions Market Share by Region (2018-2029)
Figure 32. China Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 40. Mexico Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cell and Gene Therapy Solutions Market Share by Country (2018-2029)
Figure 44. Turkey Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cell and Gene Therapy Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Bluebird Bio Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 48. Solid Biosciences Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 49. Novartis Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 50. Biomarin Pharmaceutical Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 51. Uniqure Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 52. Spark Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 53. Alaunos Therapeutics Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 54. Homology Medicines Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 55. Biogen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 56. Legend Biotech Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 57. CARsgen Revenue Growth Rate in Cell and Gene Therapy Solutions Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed